Study summary

Adding low-dose whole-brain radiation lengthened remission without harming thinking

R-MPV-A with or without low-dose brain radiation · 91 people, randomized phase 2 · Published February 2026, Neuro-Oncology

78.7%2-year progression-free with low-dose radiation, vs 54%

What was tested

R-MPV-A chemoimmunotherapy with or without reduced-dose whole-brain radiotherapy (23.4 Gy) in newly diagnosed PCNSL.

What they found

What it means

An alternative to transplant for patients who cannot have high-dose chemotherapy.

Neuro Oncol, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.